Watch MEDS. Know when insiders buy.
One email the day a filing lands. Free.
MEDS
DataMeds AI, Inc.
3.76
−0.88 −18.97%
USD · close Sep 18
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
37
FLAG · shorts 37
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $11.5MP/E —DIV YIELD —FCF YIELD —REV TTM $8M −78.2%NET INCOME −$88.3MNET DEBT $29.3M52W 0.85 – 57.50SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $1.8M | −77.2% | 10.2% | −$7.3M | −$18.4M | — | -7.13 | −$2.9M | — | — | Aug 17 |
| Q1 2026 · Mar 31 | $1.6M | −85.6% | 10.9% | −$6M | −$7.7M | — | -0.07 | −$3.4M | — | — | Aug 17 |
| Q4 2025 · Dec 31derived | $1.7M | −86.5% | -470.2% | −$25.4M | −$27.9M | — | -0.25 | −$6.3M | — | — | Mar 20 |
| Q3 2025 · Sep 30 | $3M | −46.9% | 7.7% | −$31.5M | −$34.3M | — | -0.46 | −$1.1M | — | — | Nov 19 |
| Q2 2025 · Jun 30 | $7.8M | +17391.8% | 6.5% | −$5.5M | −$6.7M | — | -5.40 | −$2.1M | — | — | Aug 17 |
| Q1 2025 · Mar 31 | $10.9M | — | 6.4% | −$31.3M | −$32.4M | — | -0.62 | −$1.3M | — | — | Aug 17 |
| Q4 2024 · Dec 31derived | $12.4M | — | 10.1% | −$3.7M | −$4.3M | — | -0.10 | −$2.6M | — | — | Mar 20 |
| Q3 2024 · Sep 30 | $5.7M | — | 9.2% | −$1.7M | −$1.9M | — | -0.04 | $1M | — | — | Nov 19 |
| Q2 2024 · Jun 30 | $45K | — | -5.9% | −$573K | −$574K | — | -0.01 | $330K | — | — | Nov 19 |
| Q1 2024 · Mar 31 | — | — | — | −$80K | −$83K | — | 0.00 | $31K | — | — | Nov 19 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $23.3M | -27.5% | −$93.7M | −$101.3M | -433.9% | -1.43 | −$10.9M | — | — | — | — |
| FY2024 · to Dec 31 | $18.1M | 9.7% | −$6.1M | −$6.9M | -37.8% | -0.15 | −$1.2M | — | — | — | — |
| FY2023 · to Dec 31 | — | — | −$2.9M | −$2.9M | — | -0.06 | −$349K | — | — | — | — |
Every number comes from DataMeds AI, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.